Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,019 | -3,627 | -834 | -3,700 | -2,733 |
| Depreciation Amortization | 20 | 14 | 7 | 40 | 32 |
| Accounts receivable | 112 | 131 | 150 | N/A | -97 |
| Accounts payable and accrued liabilities | 103 | 218 | 31 | N/A | -106 |
| Other Working Capital | 343 | 295 | 157 | -220 | -47 |
| Other Operating Activity | 2,513 | 1,303 | -20 | 3,000 | 2,788 |
| Operating Cash Flow | $-2,928 | $-1,666 | $-509 | $-880 | $-163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 1 | 4 | -1 | -1 |
| Investing Cash Flow | $N/A | $1 | $4 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,999 | 1,749 | N/A | N/A | N/A |
| Other Financing Activity | -276 | -145 | 0 | 0 | 0 |
| Financing Cash Flow | $1,723 | $1,604 | $N/A | $0 | $N/A |
| Beginning Cash Position | 1,269 | 1,269 | 1,269 | 2,150 | 2,155 |
| End Cash Position | 64 | 1,208 | 764 | 1,260 | 1,992 |
| Net Cash Flow | $-1,205 | $-61 | $-505 | $-880 | $-164 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,928 | -1,666 | -509 | -880 | -163 |
| Capital Expenditure | 0 | -4 | 0 | N/A | -1 |
| Free Cash Flow | -2,928 | -1,670 | -509 | -880 | -164 |